Announce Date | 04/24/2025 |
EPS Normalized Actual | $0.79 In Line |
EPS GAAP Actual | $0.79 In Line |
Revenue Actual | $3.463B |
Revenue Surprise | Beat by $3463M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.154 |
EPS GAAP Estimate | $1.154 |
Revenue Estimate | $4.06439325B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 0 | INF | 0 | 0 | 1 |
Dec 2026 | 4.46 | 8.67 | 4.38 | 4.54 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.65 | 0.65 | 3.463B | -6.93% | 3463M |
FQ4 2024 (Dec 2024) | 0.59 | 0.59 | 3.357B | -4.29% | 3357M |
FQ3 2024 (Sep 2024) | 0.72 | 0.72 | 3.584B | 0.45% | 3584M |
FQ2 2024 (Jun 2024) | 0.7 | 0.7 | 3.711B | 7.09% | 3711M |
FQ1 2024 (Mar 2024) | 0.59 | 0.59 | 3.703B | 9.56% | 3703M |
FQ4 2023 (Dec 2023) | 0.7 | 0.7 | 3.501B | 14.28% | 3501M |
FQ3 2023 (Sep 2023) | 0.78 | 0.78 | 3.568B | 13% | 3568M |
FQ2 2023 (Jun 2023) | 1.05 | 1.05 | 3.448B | 3.1% | 3448M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
1.154
Consensus Revenue Estimates
4.06439325B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.0178 | -- | 0.96844 | 1.04507 | 2 |
FQ3 2027 (Sep 2027) | 1.0372 | -- | 0.9869 | 1.06499 | 2 |
FQ2 2027 (Jun 2027) | 1.0937 | -- | 1.04066 | 1.123 | 2 |
FQ1 2027 (Mar 2027) | 0.9496 | -- | 0.90355 | 0.97504 | 2 |
FQ4 2026 (Oct 2026) | 1.2285 | -- | 1.20436 | 1.25196 | 3 |
FQ3 2026 (Jul 2026) | 1.3249 | -- | 1.29886 | 1.3502 | 3 |
FQ2 2026 (Jun 2026) | 1.5 | -- | 1.4599 | 1.53123 | 3 |
FQ1 2026 (Mar 2026) | 1.32 | 50.76 | 1.28471 | 1.34748 | 3 |
FQ4 2025 (Oct 2025) | 1.168 | 49.49 | 1.14505 | 1.1903 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.94B | -- | 3.79B | 4.02B | 3 |
FQ3 2027 (Sep 2027) | 3.91B | -- | 3.76B | 3.99B | 3 |
FQ2 2027 (Jun 2027) | 3.88B | -- | 3.73B | 3.96B | 3 |
FQ1 2027 (Mar 2027) | 3.85B | -- | 3.71B | 3.93B | 3 |
FQ4 2026 (Oct 2026) | 4.07B | -- | 4B | 4.12B | 4 |
FQ3 2026 (Jul 2026) | 4.23B | -- | 4.17B | 4.29B | 5 |
FQ2 2026 (Jun 2026) | 4.23B | -- | 4.14B | 4.3B | 5 |
FQ1 2026 (Mar 2026) | 4.09B | 15.25 | 4B | 4.15B | 6 |
FQ4 2025 (Oct 2025) | 3.98B | 15.55 | 3.91B | 4.03B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.65 | 0.65 | 100% | |
FQ4 2024 (Dec 2024) | 0.59 | 0.59 | 100% | |
FQ3 2024 (Sep 2024) | 0.72 | 0.72 | 100% | |
FQ2 2024 (Jun 2024) | 0.7 | 0.7 | 100% | |
FQ1 2024 (Mar 2024) | 0.59 | 0.59 | 100% | |
FQ4 2023 (Dec 2023) | 0.7 | 0.7 | 100% | |
FQ3 2023 (Sep 2023) | 0.78 | 0.78 | 100% | |
FQ2 2023 (Jun 2023) | 1.05 | 1.05 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $3.46B | $3463M | 100% |
FQ4 2024 (Dec 2024) | $0B | $3.36B | $3357M | 100% |
FQ3 2024 (Sep 2024) | $0B | $3.58B | $3584M | 100% |
FQ2 2024 (Jun 2024) | $0B | $3.71B | $3711M | 100% |
FQ1 2024 (Mar 2024) | $0B | $3.7B | $3703M | 100% |
FQ4 2023 (Dec 2023) | $0B | $3.5B | $3501M | 100% |
FQ3 2023 (Sep 2023) | $0B | $3.57B | $3568M | 100% |
FQ2 2023 (Jun 2023) | $0B | $3.45B | $3448M | 100% |